公开(公告)号：US20240343822A1

公开(公告)日：2024-10-17

申请号：US18580460

申请日：2022-07-19

Applicant: MORPHOSYS AG

Inventor： Stefan HÄRTLE ,  Roland BAUMGARTNER

IPC: C07K16/28 ,  A61K31/138 ,  A61K31/167 ,  A61K31/573 ,  A61K39/00 ,  A61P13/12 ,  A61P37/06

CPC classification number: C07K16/2896 ,  A61K31/138 ,  A61K31/167 ,  A61K31/573 ,  A61P13/12 ,  A61P37/06 ,  A61K2039/505 ,  A61K2039/545

Abstract: The present disclosure relates to the treatment of anti-PLA2R-positive membranous nephropathy. The anti-CD38 antibody, MOR202, is efficacious when administered to patients at certain dosage regimens.